Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Contemporary management of dyslipidemia in high-risk patients: targets still not met.
Yan AT, Yan RT, Tan M, Hackam DG, Leblanc KL, Kertland H, Tsang JL, Jaffer S, Kates ML, Leiter LA, Fitchett DH, Langer A, Goodman SG; Vascular Protection (VP) and Guidelines Oriented Approach to Lipid Lowering (GOALL) Registries Investigators. Yan AT, et al. Among authors: leblanc kl. Am J Med. 2006 Aug;119(8):676-83. doi: 10.1016/j.amjmed.2005.11.015. Am J Med. 2006. PMID: 16887414
Non-vitamin K antagonist oral anticoagulant (NOAC) use and dosing in Canadian practice: Insights from the optimising pharmacotherapy in the management approach to lowering risk in atrial fibrillation (OPTIMAL AF) Programme.
Leblanc K, Bell AD, Ezekowitz JA, Tan MK, Laflamme D, Goldin L, Habert J, Lin PJ, Saunders K, Ngui D, Ng AP, Desroches J, Goodman SG; OPTIMAL AF Investigators. Leblanc K, et al. Int J Clin Pract. 2020 Dec;74(12):e13625. doi: 10.1111/ijcp.13625. Epub 2020 Aug 27. Int J Clin Pract. 2020. PMID: 33448547
Current Gaps in the Provision of Safe and Effective Anticoagulation in Atrial Fibrillation and the Potential for Factor XI-Directed Therapeutics.
Goodman SG, Roy D, Pollack CV Jr, Leblanc K, Kwaku KF, Barnes GD, Bonaca MP, True Hills M, Campello E, Fanikos J, Connors JM, Weitz JI. Goodman SG, et al. Crit Pathw Cardiol. 2024 Jun 1;23(2):47-57. doi: 10.1097/HPC.0000000000000351. Epub 2024 Feb 21. Crit Pathw Cardiol. 2024. PMID: 38381695 Free PMC article. Review.
Vascular quality of care pilot study: how admission to a vascular surgery service affects evidence-based pharmacologic risk factor modification in patients with lower extremity peripheral arterial disease.
Steenhof N, Le Piane F, Leblanc K, Eisenberg NR, Kwan Y, Malmberg C, Papadopoulos A, Roche-Nagle G. Steenhof N, et al. Vasc Health Risk Manag. 2014 Jun 4;10:333-40. doi: 10.2147/VHRM.S61966. eCollection 2014. Vasc Health Risk Manag. 2014. PMID: 24940068 Free PMC article.
The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure.
McKelvie RS, Moe GW, Ezekowitz JA, Heckman GA, Costigan J, Ducharme A, Estrella-Holder E, Giannetti N, Grzeslo A, Harkness K, Howlett JG, Kouz S, Leblanc K, Mann E, Nigam A, O'Meara E, Rajda M, Steinhart B, Swiggum E, Le VV, Zieroth S, Arnold JM, Ashton T, D'Astous M, Dorian P, Haddad H, Isaac DL, Leblanc MH, Liu P, Rao V, Ross HJ, Sussex B. McKelvie RS, et al. Can J Cardiol. 2013 Feb;29(2):168-81. doi: 10.1016/j.cjca.2012.10.007. Epub 2012 Nov 30. Can J Cardiol. 2013. PMID: 23201056 Review.
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation.
Andrade JG, Aguilar M, Atzema C, Bell A, Cairns JA, Cheung CC, Cox JL, Dorian P, Gladstone DJ, Healey JS, Khairy P, Leblanc K, McMurtry MS, Mitchell LB, Nair GM, Nattel S, Parkash R, Pilote L, Sandhu RK, Sarrazin JF, Sharma M, Skanes AC, Talajic M, Tsang TSM, Verma A, Verma S, Whitlock R, Wyse DG, Macle L; Members of the Secondary Panel. Andrade JG, et al. Can J Cardiol. 2020 Dec;36(12):1847-1948. doi: 10.1016/j.cjca.2020.09.001. Epub 2020 Oct 22. Can J Cardiol. 2020. PMID: 33191198
53 results